TNF-alpha and IFN-gamma: Two Routes to Intestinal Barrier Dysfunction
TLR Signaling in IBD Begins at the Epithelium
Anti-Drug Antibodies: The Quiet Tax on Every IBD Biologic
TL1A Beyond IBD: What Happens When a Gut Target Goes Systemic
Oral Drug Delivery in IBD: Why the Best New Drugs Still Come as Injections
TL1A Bispecifics: The Race to Break the IBD Efficacy Ceiling
TL1A in IBD: Why the Whole Field Suddenly Cares About One Ligand
Create an account to access this functionality.
Discover the advantages
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
